Skip to main content

SB239 Alabama 2023 Session

Updated Feb 22, 2026

Summary

Session
Regular Session 2023
Title
Relating to Opioid Addiction Treatment; to repeal the Medication Assisted Treatment of Opioid Use Act of 2019, codified as Sections 20-2-300 through 20-2-302, Code of Alabama 1975, that provide for adoption of rules governing use of buprenorphine in the treatment of opioid addiction and a standing working group to assist in drafting the rules.
Summary

SB239 repeals Alabama's Medication Assisted Treatment of Opioid Use Act of 2019, removing state rules and a standing working group for buprenorphine treatment of opioid addiction.

What This Bill Does

It repeals the MAT Act of 2019 (Sections 20-2-300 through 20-2-302), which required the Alabama Board of Medical Examiners to adopt rules governing buprenorphine treatment in nonresidential settings and to use a standing working group to help draft those rules. As a result, state rules governing buprenorphine treatment in nonresidential settings, including aspects like dosage, screening, therapy, and record-keeping, would no longer be in effect. The repeal is intended to address conflicts with changes in federal law and policy governing medication-assisted treatment. The repeal becomes effective on the first day of the third month after passage and governor’s approval.

Who It Affects
  • Physicians, clinics, and other providers who treat opioid addiction with buprenorphine in nonresidential settings would no longer be bound by the MAT Act’s state rules.
  • The Alabama Board of Medical Examiners and the standing working group that assisted in drafting MAT Act rules would lose their MAT Act-related rulemaking authority.
Key Provisions
  • Repeal of Sections 20-2-300 through 20-2-302, known as The Medication Assisted Treatment of Opioid Use Act of 2019, including the provisions for developing and adopting rules by the Alabama Board of Medical Examiners and the standing working group.
  • Effective date: the act becomes effective on the first day of the third month following its passage and governor approval (or otherwise becoming law).
AI-generated summary using openai/gpt-5-nano on Feb 22, 2026. May contain errors — refer to the official bill text for accuracy.
Subjects
Medication Assisted Treatment of Opioid Use Act, repealed

Bill Actions

S

Enacted

S

Enrolled

H

Ready to Enroll

H

Read a Third Time and Pass

H

On Third Reading in Second House

H

Read Second Time in Second House

H

Reported Out of Committee in Second House

H

Reported Favorably from House Health

H

Referred to Committee to House Health

S

Read First Time in Second House

S

Read a Third Time and Pass

S

Read a Third Time and Pass

S

On Third Reading in House of Origin

S

Read Second Time in House of Origin

S

Reported Out of Committee in House of Origin

S

Reported Favorably from Senate Healthcare

S

Introduced and Referred to Senate Healthcare

S

Read First Time in House of Origin

Calendar

Hearing

House Health Hearing

Room 206 at 10:30:00

Hearing

Senate Healthcare Hearing

Room 304 at 12:00:00

Bill Text

Votes

Documents

Source: Alabama Legislature